There are up to 80 diseases treated with stem cells (bone marrow, peripheral blood stem cells (PBSC) or cord blood. Many of these diseases affect New Yorkers and individuals, especially from various ethnic groups, whom have limited options when it comes to finding a donor.
According to HRSA.gov (2015) more people who have difficulty finding a matching donor, special emphasis is placed on registering marrow donors and collecting cord blood units from these communities:
According to CW Bill Young Transplantation Program (2015) out of 11 million registered bone marrow donors:
According to C.W. Bill Young Transplantation Program (2015) out of 193,000 registered cord blood donors:
According to New York State Department of Health (2015) New York State Population consists of 19,570,261 people:
New York City consists of 8,400,000 people:
Diseases that can be treated by stem cells that are leading incidents and deaths of New Yorkers:
Sickle Cell Anemia
New York ranked fourth in National Rate of incidents with Leukemia. In 2012, 54% of New York State’s causes of death were heart disease and malignant neoplasms (cancer). Sickle Cell Disease affects 90,000 to 100,000 Americans. SCD occurs among about 1 out of every 500 Black or African-American births. SCD occurs among about 1 out of every 36,000 Hispanic-American births.
According to CDC (2010) Cancer, heart disease, stroke and diabetes are among the leading causes of death in Asian Americans or Pacific Islanders. Thalassemia is a common sub-Saharan Africa, the Mediterranean Basin, the Middle East, South Asia and South East Asia. Thalassemia resulted in 25,000 deaths in 2013 down from 36,000 deaths in 1990. In 2005 in Saudi Arabia a mandatory pre-marital test includes HB electrophoresis was launched and aimed to decrease the incidence of sickle cell disease and Thalassemia. The disease affects diabetes In Saudi Arabia, 24% of the population, with 23 % in Kuwait, 22% in Bahrain, 20% in Qatar and 19% in the United Arab Emirates.
According to CDC.gov (2015) cardiovascular disease causes about 45% of early deaths in the Gulf region. The overall estimated prevalence of hypertension was 29.5%, which indicates a higher prevalence of hypertension among Arabs compared to people from the sub-Saharan African (27.6%). In sub-Saharan Africa, hypertension remains the most threatening risk factor, with national prevalence ranging between 15% to 30% in adults.
Each year scientist become closer to discovering more treatment options for more diseases that will increase the survival rates for all those affected.